ArticleOncotarget2017

Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.

Baoan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.